Search Articles

Transplantation and Surgical Strategies in Patients With Neuroendocrine Liver Metastases: Protocol of Four Systematic Reviews

To increase the resectability and to reduce the high rate of metastatic relapse, neoadjuvant and adjuvant treatment options need to be evaluated.

Reto Stump, Silvia Haueis, Nicola Kalt, Christoph Tschuor, Përparim Limani, Dimitri A. Raptis, Milo A. Puhan, Stefan Breitenstein

JMIR Res Protoc 2013;2(2):e58

Download Citation: END BibTex RIS

A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study (ANZ1301 DOMINO)

[36, 37]; satisfaction with decision score will be high [38]; and there will be no change in outcomes between those who decided to receive neoadjuvant chemotherapy with those who decided not to have neoadjuvant therapy.Exploratory HypothesesCorrelation will

Nicholas Zdenkowski, Phyllis Butow, Elizabeth Hutchings, Charles Douglas, Joseph R Coll, Frances M Boyle

JMIR Res Protoc 2016;5(2):e88

Download Citation: END BibTex RIS

Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial Protocol

 treatment.

Ranyell MSB Spencer, Samuel Aguiar Junior, Fabio O Ferreira, Paulo R Stevanato Filho, Bruna EC Kupper, Maria LG Silva, Celso A Mello, Tiago S Bezerra, Ademar Lopes

JMIR Res Protoc 2017;6(5):e97

Download Citation: END BibTex RIS

Engagement in an Interactive App for Symptom Self-Management during Treatment in Patients With Breast or Prostate Cancer: Mixed Methods Study

Neoadjuvant chemotherapy is administered at the oncology clinic at different treatment intervals, depending on the cytotoxic drugs that are given [43].

Marie-Therése Crafoord, Maria Fjell, Kay Sundberg, Marie Nilsson, Ann Langius-Eklöf

J Med Internet Res 2020;22(8):e17058

Download Citation: END BibTex RIS

Daily Collection of Self-Reporting Sleep Disturbance Data via a Smartphone App in Breast Cancer Patients Receiving Chemotherapy: A Feasibility Study

(PRO) data into cancer patients’ care is still in the embryonic stage, noteworthy to date are demonstrations of the feasibility of mHealth—and specifically the use of mobile phones—to assist in the collection of PROs on disease-related vital signs [2,3], treatment-related

Yul Ha Min, Jong Won Lee, Yong-Wook Shin, Min-Woo Jo, Guiyun Sohn, Jae-Ho Lee, Guna Lee, Kyung Hae Jung, Joohon Sung, Beom Seok Ko, Jong-Han Yu, Hee Jeong Kim, Byung Ho Son, Sei Hyun Ahn

J Med Internet Res 2014;16(5):e135

Download Citation: END BibTex RIS

Oncosurgical Management of Liver Limited Stage IV Colorectal Cancer: Preliminary Data and Protocol for a Randomized Controlled Trial

An increasing number of surgical strategies and better neoadjuvant treatment are bringing more patients to resection of liver metastases with prolonged survival in a select group of patients who present with synchronous disease [3].It is clear that the optimal

Paul Sutton, Dale Vimalachandran, Graeme Poston, Stephen Fenwick, Hassan Malik

JMIR Res Protoc 2018;7(5):e125

Download Citation: END BibTex RIS

Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol

In order to improve the radicality of surgical resection and the long-term survival after surgical resection, many trials have been performed to study the effect of neoadjuvant chemo and/or radiation therapy [14-17].

Bo Jan Noordman, Joel Shapiro, Manon CW Spaander, Kausilia K Krishnadath, Hanneke WM van Laarhoven, Mark I van Berge Henegouwen, Grard AP Nieuwenhuijzen, Richard van Hillegersberg, Meindert N Sosef, Ewout W Steyerberg, Bas PL Wijnhoven, J Jan B van Lanschot

JMIR Res Protoc 2015;4(2):e79

Download Citation: END BibTex RIS

Development and Feasibility of a Mobile Health–Supported Comprehensive Intervention Model (CIMmH) for Improving the Quality of Life of Patients With Esophageal Cancer After Esophagectomy: Prospective, Single-Arm, Nonrandomized Pilot Study

Esophagectomy is the major curative treatment option and is often performed in combination with neoadjuvant chemotherapy or chemoradiotherapy [2]. The surgery is considered extensive and entails a more than 40% risk of postoperative complications [3,4].

Chao Cheng, Rainbow Tin Hung Ho, Yan Guo, Mengting Zhu, Weixiong Yang, Yiran Li, Zhenguo Liu, Shuyu Zhuo, Qi Liang, Zhenghong Chen, Yu Zeng, Jiali Yang, Zhanfei Zhang, Xu Zhang, Aliza Monroe-Wise, Sai-Ching Yeung

J Med Internet Res 2020;22(8):e18946

Download Citation: END BibTex RIS

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study

Accepted neoadjuvant chemotherapy regimens generally consist of a platinum drug combined with a fluoropyrimidine. In addition, an anthracycline or taxane may have been added according to local protocol.

Rosa T van der Kaaij, Hidde JW Braam, Henk Boot, Maartje Los, Annemieke Cats, Cecile Grootscholten, Jan HM Schellens, Arend GJ Aalbers, Alwin DR Huitema, Catherijne AJ Knibbe, Djamila Boerma, Marinus J Wiezer, Bert van Ramshorst, Johanna W van Sandick

JMIR Res Protoc 2017;6(7):e136

Download Citation: END BibTex RIS

Virtual Management of Patients With Cancer During the COVID-19 Pandemic: Web-Based Questionnaire Study

In addition, 53% (n=118) preferred to continue first-line palliative treatment.

Emad Tashkandi, Ahmed Zeeneldin, Amal AlAbdulwahab, Omima Elemam, Shereef Elsamany, Wasil Jastaniah, Shaker Abdullah, Mohammad Alfayez, Abdul Rahman Jazieh, Humaid O Al-Shamsi

J Med Internet Res 2020;22(6):e19691

Download Citation: END BibTex RIS